mcmorgan & co. LLC invests $1.78 million in Prestige Consumer Healthcare Inc. (NYSE:PBH)

mcmorgan & co. LLC bought a new position in Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 25,908 shares of the company’s stock, valued at approximately $1,784,000.

Other large investors have also made changes to their positions in the company. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare in the second quarter valued at about $26,000. Quest Partners LLC increased its holdings in Prestige Consumer Healthcare by 2,826.7% during the second quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after acquiring an additional 424 shares in the last quarter. EverSource Wealth Advisors LLC boosted its holdings in Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after acquiring an additional 208 shares in the last quarter. Gladius Capital Management LP bought a new stake in Prestige Consumer Healthcare in the second quarter valued at approximately $35,000. Finally, ORG Partners LLC bought a new stake in Prestige Consumer Healthcare in the second quarter valued at approximately $39,000. Institutional investors own 99.95% of the company’s shares.

Changes in Analyst Ratings

Several brokerages have recently issued reports on PBH. DA Davidson raised their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and issued a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $94.20.

Read the latest stock analysis on PBH

Prestige Consumer Healthcare stock performance

Shares of NYSE:PBH opened at $71.35 on Friday. The company has a market cap of $3.54 billion, a price-to-earnings ratio of 17.11, a P/E/G ratio of 2.04 and a beta of 0.48. The company’s 50-day simple moving average is $71.22, and its 200-day simple moving average is $69.64. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23, and a quick ratio of 1.90. Prestige Consumer Healthcare Inc. it has a fifty-two week low of $56.34 and a fifty-two week high of $75.80.

Prestige Consumer Healthcare (NYSE:PBH – Get Your Free Report ) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million for the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue for the quarter was down 4.4% on a year-over-year basis. In the same period last year, the company posted EPS of $1.06. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current year.

Prestige Consumer Healthcare Company Profile

(Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

Further reading

Want to see what other hedge funds own PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trading for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).

Receive daily news and reviews for Prestige Consumer Healthcare – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.